The Center for Biologics Evaluation and Research is offering grants for research projects aiming to enhance technologies in advanced manufacturing of biologic products, specifically focusing on vaccines for influenza and emerging infectious diseases. Clinical trials are excluded, with a deadline of May 18, 2021.
Opportunity ID: 332098
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-21-033 |
| Funding Opportunity Title: | Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trials Not Allowed |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Agriculture Consumer Protection Food and Nutrition |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.103 — Food and Drug Administration Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 14, 2021 |
| Last Updated Date: | Mar 14, 2021 |
| Original Closing Date for Applications: | May 18, 2021 |
| Current Closing Date for Applications: | May 18, 2021 |
| Archive Date: | Jun 17, 2021 |
| Estimated Total Program Funding: | $2,000,000 |
| Award Ceiling: | $500,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | County governments Public housing authorities/Indian housing authorities Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education City or township governments Native American tribal governments (Federally recognized) Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments State governments |
| Additional Information on Eligibility: | Higher Education InstitutionsPublic/State Controlled Institutions of Higher Education Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education: o Hispanic-serving Institutionso Historically Black Colleges and Universities (HBCUs)o Tribally Controlled Colleges and Universities (TCCUs) o Alaska Native and Native Hawaiian Serving Institutionso Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)Nonprofits Other Than Institutions of Higher EducationNonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit OrganizationsSmall Businesses For-Profit Organizations (Other than Small Businesses) GovernmentsState Governments County Governments City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) U.S. Territory or Possession OtherIndependent School Districts Public Housing Authorities/Indian Housing Authorities Native American Tribal Organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Regional Organizations |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: |
CBER seeks to support several research projects that are focused on developing novel technologies for the advanced manufacturing of complex biologic products or innovative analytical approaches for improving product manufacturing and quality. |
| Link to Additional Information: | Full Announcement of RFA-FD-21-033 on NIH Guide for Grants and Contracts |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Gordana Zuber
Grant Management Specialist Phone: 301-348/1747 Email:gordana.zuber@fda.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | Gordana Zuber Grant Management Specialist Phone: 301-348/1747 Email: gordana.zuber@fda.hhs.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.103 | RFA-FD-21-033 | FORMS F | PKG00265902 | Mar 14, 2021 | May 18, 2021 | View |
Package 1
Mandatory forms
332098 RR_SF424_2_0-2.0.pdf
332098 PHS398_CoverPageSupplement_5_0-5.0.pdf
332098 RR_OtherProjectInfo_1_4-1.4.pdf
332098 PerformanceSite_2_0-2.0.pdf
332098 RR_KeyPersonExpanded_2_0-2.0.pdf
332098 RR_Budget_1_4-1.4.pdf
332098 PHS398_ResearchPlan_4_0-4.0.pdf
332098 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
332098 RR_SubawardBudget30_1_4-1.4.pdf
332098 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
